sameAs
Molecular mechanisms of renal blood flow autoregulationRole of endothelin in uteroplacental circulation and fetal vascular functionProteomics investigations of HDL: challenges and promiseMilk fat globule epidermal growth factor VIII signaling in arterial wall remodelingDyslipidaemia, hypercoagulability and the metabolic syndromeDrug therapies in the secondary prevention of cardiovascular diseases: Successes, shortcomings and future directionsLow-molecular-weight heparins in acute coronary syndromesMacrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque ruptureSignificance of aspirin and clopidogrel resistance in patients undergoing percutaneous coronary interventionsLipoprotein(a): current perspectivesManagement of primary aldosteronism: its complications and their outcomes after treatmentGinseng compounds: an update on their molecular mechanisms and medical applicationsHypocholesterolemiaMicrocirculation Alteration and Biomarker Dilemma in Early Septic Shock Diagnosis and Treatment.Nitric Oxide as a Marker for Levo-Thyroxine Therapy in Subclinical Hypothyroid Patients.Endothelial dysfunction in sepsis.Mechanisms of vascular hyporesponsiveness in septic shock.The hemodynamics of septic shock: a historical perspective.Host innate immune responses to microbial pathogens.Cardiovascular dysfunction in sepsis: from basic mechanisms to clinical management.Cardiovascular effects of current and future anti-obesity drugs.Use of BNP and CRP as biomarkers in assessing cardiovascular disease: diagnosis versus risk.Editorial: avenue to arteriogenesis.Gene-lifestyle and gene-pharmacotherapy interactions in obesity and its cardiovascular consequences.Hypoxia-inducible factor-1 in arterial disease: a putative therapeutic target.Apoptosis and Acute Brain Ischemia in Ischemic Stroke.The role of renal nerve ablation for the management of resistant hypertension and other disease conditions: benefits and concerns.Chloride Channels - New Targets for the Prevention of Stroke.Effects and Perspectives of Chinese Patent Medicines for Tonifying Qi and Promoting Blood Circulation on Patients with Cerebral Infarction.Inflammation, sleep, obesity and cardiovascular disease.The etiology of hypertension in the metabolic syndrome part two: the gene-environment interaction.Clinical management of the cardiovascular failure in sepsis.Recent developments on coronary microvasculopathy after heart transplantation: a new target in the therapy of cardiac allograft vasculopathy.Cardiac protection by volatile anaesthetics: a review.Clinical aspects of melatonin in the acute coronary syndrome.The complement cascade: new avenues in stroke therapy.Lipids and non-cardiac vascular disease: a lecture overview.How to identify subjects with poly-vascular disease?Near-infrared spectroscopy (NIRS): a non-invasive in vivo methodology for analysis of brain vascular and metabolic activities in real time in rodents.Endothelin-1 and nitric oxide in the pathogenesis of urinary tract disorders secondary to bladder outlet obstruction.
P1433
Q26825286-7C58A757-2226-423F-8E08-C2657C30EAA6Q26828020-940D6811-47B1-4886-B36F-88AC6573F9D2Q27000995-9066750C-97ED-404A-9B73-405602DCCA34Q27013859-5BF4906C-D41D-4CDF-9284-58190E20E4D7Q28199524-BE42450C-D0A1-4E69-9BD4-0494E1D79248Q28199528-4E491206-9B23-4B94-9F0C-AB2EC584ACB6Q28211234-3697041E-2CB9-4F7C-AFB3-2D0EA57BCCD6Q28212820-3F88E848-3F45-43CD-8220-1C29232960E0Q28222258-06336C46-6002-4280-8468-FBB5B94013D9Q28236462-96E6129D-8A30-4E64-91A9-7AAE329E18AEQ28240784-6D61F715-9C6C-4BFB-A990-FC39688E6331Q28251905-F81A8EF0-0698-4600-B2A6-145FB3D0D1DCQ28287791-8387D74B-AB27-4DBE-9C1E-8842D48CC0D7Q48200006-160DAE05-0E4B-493E-A0F5-A69E46AB57E6Q48224846-155E602F-CFB8-4696-ABFD-91375C260045Q48277218-3F611957-D461-4A93-85F1-717927350EDDQ48277227-B2C4FFC0-75AB-4B36-934B-9605D07D237AQ48277239-3137344E-9FF7-44C6-8BA6-7BC7F0FBCF72Q48277247-BA5D80E7-BA4C-4A5E-AA47-8AC559DBA26FQ48277257-44E683CF-66AA-40F7-A032-92B7ED58E2FEQ48290932-50B6E194-DCD0-4E80-8517-B77E87F34FE3Q48292025-5D33DB9B-A976-4C73-8078-5760AF28C0BAQ48303143-FEB6BFB3-20A4-4045-9C5F-B985439CD026Q48327603-22BFFF71-8F1F-4624-85F6-9A71AAD4915CQ48342756-F1C33735-A989-418E-ACC8-1A277E8DAE5FQ48437015-A15F0025-7347-4B9A-8CD2-056398C80BDCQ48443445-DEEC2ADB-A062-42CE-9502-CD4C0E2B7CFCQ48469221-0E9463FE-B70F-45E7-88F8-5277CF65EE56Q48469230-7C73966C-D70D-46EE-8320-ED3AAE54253EQ48472029-C8111F7B-3C07-486A-A1D8-FAA9801D1F97Q48486522-F06C3F08-6ECA-46EB-83F5-E60F8DCA8E49Q48496620-1F283875-9659-4A17-BFA2-C026355599E1Q48497990-958ABDAC-BDAB-4902-AA64-7A290C77C5D9Q48502383-9AEA8EB5-65E6-43C6-B6B2-3EFD674498CEQ48523265-D935E1F4-A6E7-41ED-BEBD-FB8A24836C64Q48523279-E416437D-B373-472B-A840-24C66EE917FCQ48530365-DC3C2FA9-E7E4-41D9-917C-1D2FD69DAC9EQ48540172-4E464A8E-06B7-48B9-947B-967D9E5EED28Q48550687-DD8EEDD6-7E56-4935-BE5E-A624685154F4Q48566286-1362743A-EAAF-46E3-BFE3-BC93B4163611
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Bentham Science Publishers
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
name
Current Vascular Pharmacology
@ast
Current Vascular Pharmacology
@de
Current Vascular Pharmacology
@en
Current Vascular Pharmacology
@es
Current Vascular Pharmacology
@it
Current Vascular Pharmacology
@nl
type
label
Current Vascular Pharmacology
@ast
Current Vascular Pharmacology
@de
Current Vascular Pharmacology
@en
Current Vascular Pharmacology
@es
Current Vascular Pharmacology
@it
Current Vascular Pharmacology
@nl
prefLabel
Current Vascular Pharmacology
@ast
Current Vascular Pharmacology
@de
Current Vascular Pharmacology
@en
Current Vascular Pharmacology
@es
Current Vascular Pharmacology
@it
Current Vascular Pharmacology
@nl
P3181
P1055
P1058
P1156
P1277
P1476
Current and Vascular Pharmacology
@en
P236
P3181
P571
2003-01-01T00:00:00Z